Etiology and Pathogenesis of Rheumatoid Arthritis

Kelley and Firestein's Textbook of Rheumatology: Volumes 1-2, Tenth Edition

Volumn 2, Issue , 2016, Pages 1115-1166.e7

  Firestein, Gary S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85166579005     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-31696-5.00069-3     Document Type: Chapter

References (398)

1. WP Arend and GS Firestein (2012) Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis. Nat Rev Rheumatol 8 573.
2. J Sokolove, R Bromberg, KD Deane, et al. (2012) Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS ONE 7 e35296.
3. Y Okada, D Wu, G Trynka, et al. (2014) Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506 376.
4. GS Firestein and NJ Zvaifler (2002) How important are T cells in chronic rheumatoid synovitis?: II. T cell-independent mechanisms from beginning to end. Arthritis Rheum 46 298.
5. CM Weyand, KC Hicok, DL Conn, et al. (1992) The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 117 801.
6. D Van der Woude, BA Lie, E Lundström, et al. (2010) Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations. Arthritis Rheum 62 1236.
7. JM Rak, L Maestroni, N Balandraud, et al. (2009) Transfer of the shared epitope through microchimerism in women with rheumatoid arthritis. Arthritis Rheum 60 73.
8. S Raychaudhuri, C Sandor, EA Stahl, et al. (2012) Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 44 291.
9. JA Hill, S Southwood, A Sette, et al. (2003) Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 171 538.
10. SC Law, S Street, CH Yu, et al. (2012) T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles. Arthritis Res Ther 14 R118.
11. AH van der Helm-van Mil, KN Verpoort, FC Breedveld, et al. (2006) The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum 54 1117.
12. CP Kang, KW Lee, DH Yoo, et al. (2005) The influence of a polymorphism at position −857 of the tumour necrosis factor alpha gene on clinical response to etanercept therapy in rheumatoid arthritis. Rheumatology (Oxford) 44 547.
13. RC Ferreira, DF Freitag, AJ Cutler, et al. (2013) Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases. PLoS Genet 9 e1003444.
14. A Suzuki, R Yamada, X Chang, et al. (2003) Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 34 395.
15. AB Begovich, VE Carlton, LA Honigberg, et al. (2004) A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75 330.
16. EA Stahl, S Raychaudhuri, EF Remmers, et al. (2010) Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 42 508-514.
17. P Gatenby, R Lucas and A Swaminathan (2013) Vitamin D deficiency and risk for rheumatic diseases: an update. Curr Opin Rheumatol 25 184.
18. M Kekow, M Barleben, S Drynda, et al. (2013) Long-term persistence and effects of fetal microchimerisms on disease onset and status in a cohort of women with rheumatoid arthritis and systemic lupus erythematosus. BMC Musculoskelet Disord 14 325.
19. SP Linn-Rasker, AH van der Helm-van Mil, FA van Gaalen, et al. (2006) Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis 65 366.
20. SP Linn-Rasker, AH van der Helm-van Mil, FA van Gaalen, et al. (2006) Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis 65 366.
21. MF Doran, CS Crowson, WM O'Fallon, et al. (2004) The effect of oral contraceptives and estrogen replacement therapy on the risk of rheumatoid arthritis: a population based study. J Rheumatol 31 207.
22. E Lundström, H Källberg, L Alfredsson, et al. (2009) Gene-environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: all alleles are important. Arthritis Rheum 60 1597.
23. H Källberg, B Ding, L Padyukov, et al., EIRA Study Group (2011) Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis 70 508.
24. CS Crowson, EL Matteson, JM Davis 3rd, et al. (2013) Contribution of obesity to the rise in incidence of rheumatoid arthritis. Arthritis Care Res (Hoboken) 65 71.
25. SG de Aquino, S Abdollahi-Roodsaz, MI Koenders, et al. (2014) Periodontal pathogens directly promote autoimmune experimental arthritis by inducing a TLR2- and IL-1-driven Th17 response. J Immunol 192 4103.
26. JU Scher, A Sczesnak, RS Longman, et al. (2013) Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2 e01202.
27. TJ Lang (2004) Estrogen as an immunomodulator. Clin Immunol 113 224.
28. K Inoue, E Inoue and Y Imai (2013) Female sex hormones ameliorate arthritis in SKG mice. Biochem Biophys Res Commun 434 740-745.
29. Z Yan, NC Lambert, M Ostensen, et al. (2006) Prospective study of fetal DNA in serum and disease activity during pregnancy in women with inflammatory arthritis. Arthritis Rheum 54 2069.
30. JL Nelson, KA Hughes, AG Smith, et al. (1993) Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med 329 466.
31. P Brennan, J Barrett, M Fiddler, et al. (2000) Maternal-fetal HLA incompatibility and the course of inflammatory arthritis during pregnancy. J Rheumatol 27 2843.
32. E Karouzakis, Y Rengel, A Jüngel, et al. (2011) DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts. Genes Immun 12 643-652.
33. K Nakano, JW Whitaker, DL Boyle, et al. (2013) DNA methylome signature in rheumatoid arthritis. Ann Rheum Dis 72 110-117.
34. K Nakano, DL Boyle and GS Firestein (2013) Regulation of DNA methylation in rheumatoid arthritis synoviocytes. J Immunol 190 1297-1303.
35. LC Huber, M Brock, H Hemmatazad, et al. (2007) Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients. Arthritis Rheum 56 1087-1093.
36. M Horiuchi, A Morinobu, T Chin, et al. (2009) Expression and function of histone deacetylases in rheumatoid arthritis synovial fibroblasts. J Rheumatol 36 1580-1589.
37. LA Joosten, F Leoni, S Meghji, et al. (2011) Inhibition of HDAC activity by ITF2357 ameliorates joint inflammation and prevents cartilage and bone destruction in experimental arthritis. Mol Med 17 391-396.
38. Y Nakamachi, S Kawano, M Takenokuchi, et al. (2009) MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum 60 1294.
39. J Stanczyk, C Ospelt, E Karouzakis, et al. (2011) Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis Rheum 63 373-381.
40. M Kurowska-Stolarska, S Alivernini, LE Ballantine, et al. (2011) MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci U S A 108 11193-11198.
41. N Bottini and GS Firestein (2013) Epigenetics in rheumatoid arthritis: a primer for rheumatologists. Curr Rheumatol Rep 15 372.
42. MF Doran, GR Pond, CS Crowson, et al. (2002) Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum 46 625.
43. E Myasoedova, CS Crowson, HM Kremers, et al. (2010) Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum 62 1576-1582.
44. CS Crowson, EL Matteson, E Myasoedova, et al. (2011) The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum 63 633-639.
45. S Abdollahi-Roodsaz, LA Joosten, MI Koenders, et al. (2009) Local interleukin-1-driven joint pathology is dependent on toll-like receptor 4 activation. Am J Pathol 175 2004.
46. RJ Mathews, JI Robinson, M Battellino, et al. (2014) Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment. Ann Rheum Dis 73 1202-1210.
47. JY Choe, B Crain, SR Wu, et al. (2003) Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by toll-like receptor 4 signaling. J Exp Med 197 537.
48. M Brisslert, M Rehnberg and MI Bokarewa (2013) Epstein-Barr virus infection transforms CD25+ B cells into antibody-secreting cells in rheumatoid arthritis patients. Immunology 140 421-429.
49. A Kotlarz, S Tukaj, K Krzewski, et al. (2013) Human Hsp40 proteins, DNAJA1 and DNAJA2, as potential targets of the immune response triggered by bacterial DnaJ in rheumatoid arthritis. Cell Stress Chaperones 18 653-659.
50. NB Ray, DR Nieva, EA Seftor, et al. (2001) Induction of an invasive phenotype by human parvovirus B19 in normal human synovial fibroblasts. Arthritis Rheum 44 1582.
51. K Thammasri, S Rauhamäki, L Wang, et al. (2013) Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells. PLoS ONE 8 e67179.
52. L De Rycke, AP Nicholas, T Cantaert, et al. (2005) Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity. Arthritis Rheum 52 2323.
53. ER Vossenaar, TJ Smeets, MC Kraan, et al. (2004) The presence of citrullinated proteins is not specific for rheumatoid synovial tissue. Arthritis Rheum 50 3485.
54. C Anzilotti, G Merlini, F Pratesi, et al. (2006) Antibodies to viral citrullinated peptide in rheumatoid arthritis. J Rheumatol 33 647.
55. L Damjanovska, MM Thabet, EW Levarth, et al. (2010) Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis. Ann Rheum Dis 69 730.
56. GJ Pruijn, A Wiik and WJ van Venrooij (2010) The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis. Arthritis Res Ther 12 203.
57. CA Wagner, J Sokolove, LJ Lahey, et al. (2015) Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 “shared epitope” alleles. Ann Rheum Dis 74 579-586.
58. MM Nielen, D van Schaardenburg, HW Reesink, et al. (2004) Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 50 38.
59. LA van de Stadt, AR van der Horst, MH de Koning, et al. (2011) The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia. Ann Rheum Dis 70 128.
60. KD Deane, CI O'Donnell, W Hueber, et al. (2010) The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner. Arthritis Rheum 62 3161.
61. HS El-Gabalawy, DB Robinson, D Hart, et al. (2009) Immunogenetic risks of anti-cyclical citrullinated peptide antibodies in a North American Native population with rheumatoid arthritis and their first-degree relatives. J Rheumatol 6 1130.
62. FJ López-Longo, D Oliver-Miñarro, I de la Torre, et al. (2009) Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis. Arthritis Rheum 61 419.
63. EM Haisma, EW Levarht, D van der Woude, et al. (2009) Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. Arthritis Rheum 60 1923.
64. KA Kuhn, L Kulik, B Tomooka, et al. (2006) Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 116 961.
65. JA Hill, DA Bell, W Brintnell, et al. (2008) Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. J Exp Med 205 967.
66. H Burkhardt, B Sehnert, R Bockermann, et al. (2005) Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis. Eur J Immunol 35 1643.
67. R Kocijan, U Harre and G Schett (2013) ACPA and bone loss in rheumatoid arthritis. Curr Rheumatolog Rep 15 366.
68. J Shi, R Knevel, P Suwannalai, et al. (2011) Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc Natl Acad Sci U S A 108 17372-17377.
69. J Shi, LA van de Stadt, EW Levarht, et al. (2014) Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis. Ann Rheum Dis 73 780-783.
70. P Mydel, Z Wang, M Brisslert, et al. (2010) Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis. J Immunol 184 6882-6890.
71. KP Liang, H Maradit Kremers, CS Crowson, et al. (2009) Autoantibodies and the risk of cardiovascular events. J Rheumatol 36 2462-2468.
72. JP Bouvet, WJ Xin and J Pillot (1987) Restricted heterogeneity of polyclonal rheumatoid factor. Arthritis Rheum 30 998.
73. SK Lee, SL Bridges Jr, WJ Koopman, et al. (1992) The immunoglobulin kappa light chain repertoire expressed in the synovium of a patient with rheumatoid arthritis. Arthritis Rheum 35 905.
74. J Bäcklund, S Carlsen, T Höger, et al. (2002) Predominant selection of T cells specific for the glycosylated collagen type II epitope (263–270) in humanized transgenic mice and in rheumatoid arthritis. Proc Natl Acad Sci U S A 10 1073.
75. WC Watson, MA Cremer, PH Wooley, et al. (1986) Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis. Arthritis Rheum 29 1316.
76. T Sekine, K Masuko-Hongo, T Matsui, et al. (2001) Recognition of YKL-39, a human cartilage related protein, as a target antigen in patients with rheumatoid arthritis. Ann Rheum Dis 60 49.
77. G Steiner and J Smolen (2002) Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res 4 S1.
78. V Kouskoff, AS Korganow, V Duchatelle, et al. (1996) Organ-specific disease provoked by systemic autoimmunity. Cell 87 811.
79. L Mandik-Nayak and PM Allen (2005) Initiation of an autoimmune response: insights from a transgenic model of rheumatoid arthritis. Immunol Res 32 5.
80. S Hayer, M Tohidast-Akrad, S Haralambous, et al. (2005) Aberrant expression of the autoantigen heterogeneous nuclear ribonucleoprotein-A2 (RA33) and spontaneous formation of rheumatoid arthritis-associated anti-RA33 autoantibodies in TNF-alpha transgenic mice. J Immunol 175 8327.
81. V Nell-Duxneuner, K Machold, T Stamm, et al. (2010) Autoantibody profiling in patients with very early rheumatoid arthritis: a follow-up study. Ann Rheum Dis 69 169.
82. VP Nell, KP Machold, TA Stamm, et al. (2005) Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis 64 1731.
83. M Corr and NJ Zvaifler (2002) Mesenchymal precursor cells. Ann Rheum Dis 61 3.
84. HP Kiener, GF Watts, Y Cui, et al. (2010) Synovial fibroblasts self-direct multicellular lining architecture and synthetic function in three-dimensional organ culture. Arthritis Rheum 62 742.
85. PA Revell, PI Mapp, PA Lalor, et al. (1987) Proliferative activity of cells in the synovium as demonstrated by a monoclonal antibody, Ki67. Rheumatol Int 7 183.
86. X Valencia, JM Higgins, HP Kiener, et al. (2004) Cadherin-11 provides specific cellular adhesion between fibroblast-like synoviocytes. J Exp Med 200 1673.
87. TC van der Pouw Kraan, FA van Gaalen, PV Kasperkovitz, et al. (2003) Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum 48 2132.
88. S You, SA Yoo, S Choi, et al. (2014) Identification of key regulators for the migration and invasion of rheumatoid synoviocytes through a systems approach. Proc Natl Acad Sci U S A 111 550-555.
89. R Lafyatis, EF Remmers, AB Roberts, et al. (1989) Anchorage-independent growth of synoviocytes from arthritis and normal joints: stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. J Clin Invest 83 1267.
90. F Imamura, H Aono, T Hasunuma, et al. (1998) Monoclonal expansion of synoviocytes in rheumatoid arthritis. Arthritis Rheum 41 1979.
91. L Muller-Ladner, J Kriegsmann, BN Franklin, et al. (1996) Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 149 1607.
92. S Lefèvre, A Knedla, C Tennie, et al. (2009) Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med 15 1414.
93. A Lee, Y Qiao, G Grigoriev, et al. (2013) Tumor necrosis factor α induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 65 928-938.
94. B Bartok, D Hammaker and GS Firestein (2014) Phosphoinositide 3-kinase δ regulates migration and invasion of synoviocytes in rheumatoid arthritis. J Immunol 192 2063-2070.
95. JD Cañete, B Santiago, T Cantaert, et al. (2007) Ectopic lymphoid neogenesis in psoriatic arthritis. Ann Rheum Dis 66 720.
96. T Cantaert, J Kolln, T Timmer, et al. (2008) B lymphocyte autoimmunity in rheumatoid synovitis is independent of ectopic lymphoid neogenesis. J Immunol 181 785.
97. A Manzo, S Paoletti, M Carulli, et al. (2005) Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis. Eur J Immunol 35 1347.
98. T Tsubaki, S Takegawa, H Hanamoto, et al. (2005) Accumulation of plasma cells expressing CXCR3 in the synovial sublining regions of early rheumatoid arthritis in association with production of Mig/CXCL9 by synovial fibroblasts. Clin Exp Immunol 141 363.
99. YM Kang, X Zhang, UG Wagner, et al. (2002) CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis. J Exp Med 195 1325.
100. WJ Kim, YJ Kang, EM Koh, et al. (2005) LIGHT is involved in the pathogenesis of rheumatoid arthritis by inducing the expression of pro-inflammatory cytokines and MMP-9 in macrophages. Immunology 114 272.
101. RA Fava, E Notidis, J Hunt, et al. (2003) A role for the lymphotoxin/LIGHT axis in the pathogenesis of murine collagen-induced arthritis. J Immunol 171 115.
102. JS Park, MK Park, SY Lee, et al. (2012) TWEAK promotes the production of Interleukin-17 in rheumatoid arthritis. Cytokine 60 143-149.
103. K Hirota, H Yoshitomi, M Hashimoto, et al. (2007) Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med 204 2803.
104. Y Yamanishi, K Hiyama, S Ishioka, et al. (1999) Telomerase activity in the synovial tissues of chronic inflammatory and non-inflammatory rheumatic diseases. Int J Mol Med 4 513.
105. H Hata, N Sakaguchi, H Yoshitomi, et al. (2004) Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J Clin Invest 114 582.
106. D Burger, R Rezzonico, JM Li, et al. (1998) Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines. Arthritis Rheum 41 1748.
107. IB McInnes, BP Leung, RD Sturrock, et al. (1997) Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nat Med 3 189-195.
108. MA Quinn, PG Conaghan, PJ O'Connor, et al. (2005) Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial. Arthritis Rheum 52 27.
109. B Moradi, P Schnatzer, S Hagmann, et al. (2014) CD4+CD25+/highCD127low/- regulatory T cells are enriched in rheumatoid arthritis and osteoarthritis joints—analysis of frequency and phenotype in synovial membrane, synovial fluid and peripheral blood. Arthritis Res Ther 16 R97.
110. CR Ruprecht, M Gattorno, F Ferlito, et al. (2005) Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J Exp Med 201 1793.
111. XQ E, HX Meng, Y Cao, et al. (2012) Distribution of regulatory T cells and interaction with dendritic cells in the synovium of rheumatoid arthritis. Scand J Rheumatol 41 413-420.
112. JH Ju, YJ Heo, ML Cho, et al. (2012) Modulation of STAT-3 in rheumatoid synovial T cells suppresses Th17 differentiation and increases the proportion of Treg cells. Arthritis Rheum 64 3543-3552.
113. MN Svensson, SE Andersson, MC Erlandsson, et al. (2013) Fms-like tyrosine kinase 3 ligand controls formation of regulatory T cells in autoimmune arthritis. PLoS ONE 8 e54884.
114. MR Ehrenstein, JG Evans, A Singh, et al. (2004) Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 200 277.
115. S Xinqiang, L Fei, L Nan, et al. (2010) Therapeutic efficacy of experimental rheumatoid arthritis with low-dose methotrexate by increasing partially CD4(+)CD25(+)Treg cells and inducing Th1 to Th2 shift in both cells and cytokines. Biomed Pharmacother 64 463-471.
116. ME Morgan, R Flierman, LM van Duivenvoorde, et al. (2005) Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum 52 2212.
117. H Wang, SA Marsters, T Baker, et al. (2001) TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice. Nat Immunol 2 632.
118. TM Seyler, YW Park, S Takemura, et al. (2005) BLyS and APRIL in rheumatoid arthritis. J Clin Invest 115 3083.
119. PP Tak, RM Thurlings, C Rossier, et al. (2008) Atacicept in patients with rheumatoid arthritis: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose study. Arthritis Rheum 58 61.
120. BE Clausen, SL Bridges Jr, JC Lavelle, et al. (1998) Clonally-related immunoglobulin VH domains and nonrandom use of DH gene segments in rheumatoid arthritis synovium. Mol Med 4 240.
121. WP Arend and GS Firestein (2012) Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis. Nat Rev Rheumatol 8 573.
122. J Sokolove, R Bromberg, KD Deane, et al. (2012) Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS ONE 7 e35296.
123. Y Okada, D Wu, G Trynka, et al. (2014) Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506 376.
124. GS Firestein and NJ Zvaifler (2002) How important are T cells in chronic rheumatoid synovitis?: II. T cell-independent mechanisms from beginning to end. Arthritis Rheum 46 298.
125. CM Weyand, KC Hicok, DL Conn, et al. (1992) The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 117 801.
126. D Van der Woude, BA Lie, E Lundström, et al. (2010) Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations. Arthritis Rheum 62 1236.
127. JM Rak, L Maestroni, N Balandraud, et al. (2009) Transfer of the shared epitope through microchimerism in women with rheumatoid arthritis. Arthritis Rheum 60 73.
128. S Raychaudhuri, C Sandor, EA Stahl, et al. (2012) Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 44 291.
129. JA Hill, S Southwood, A Sette, et al. (2003) Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 171 538.
130. SC Law, S Street, CH Yu, et al. (2012) T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles. Arthritis Res Ther 14 R118.
131. AH van der Helm-van Mil, KN Verpoort, FC Breedveld, et al. (2006) The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum 54 1117.
132. CP Kang, KW Lee, DH Yoo, et al. (2005) The influence of a polymorphism at position −857 of the tumour necrosis factor alpha gene on clinical response to etanercept therapy in rheumatoid arthritis. Rheumatology (Oxford) 44 547.
133. RC Ferreira, DF Freitag, AJ Cutler, et al. (2013) Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases. PLoS Genet 9 e1003444.
134. A Suzuki, R Yamada, X Chang, et al. (2003) Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 34 395.
135. AB Begovich, VE Carlton, LA Honigberg, et al. (2004) A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75 330.
136. EA Stahl, S Raychaudhuri, EF Remmers, et al. (2010) Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 42 508-514.
137. P Gatenby, R Lucas and A Swaminathan (2013) Vitamin D deficiency and risk for rheumatic diseases: an update. Curr Opin Rheumatol 25 184.
138. M Kekow, M Barleben, S Drynda, et al. (2013) Long-term persistence and effects of fetal microchimerisms on disease onset and status in a cohort of women with rheumatoid arthritis and systemic lupus erythematosus. BMC Musculoskelet Disord 14 325.
139. SP Linn-Rasker, AH van der Helm-van Mil, FA van Gaalen, et al. (2006) Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis 65 366.
140. SP Linn-Rasker, AH van der Helm-van Mil, FA van Gaalen, et al. (2006) Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis 65 366.
141. MF Doran, CS Crowson, WM O'Fallon, et al. (2004) The effect of oral contraceptives and estrogen replacement therapy on the risk of rheumatoid arthritis: a population based study. J Rheumatol 31 207.
142. E Lundström, H Källberg, L Alfredsson, et al. (2009) Gene-environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: all alleles are important. Arthritis Rheum 60 1597.
143. H Källberg, B Ding, L Padyukov, et al., EIRA Study Group (2011) Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis 70 508.
144. CS Crowson, EL Matteson, JM Davis 3rd, et al. (2013) Contribution of obesity to the rise in incidence of rheumatoid arthritis. Arthritis Care Res (Hoboken) 65 71.
145. SG de Aquino, S Abdollahi-Roodsaz, MI Koenders, et al. (2014) Periodontal pathogens directly promote autoimmune experimental arthritis by inducing a TLR2- and IL-1-driven Th17 response. J Immunol 192 4103.
146. JU Scher, A Sczesnak, RS Longman, et al. (2013) Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2 e01202.
147. TJ Lang (2004) Estrogen as an immunomodulator. Clin Immunol 113 224.
148. K Inoue, E Inoue and Y Imai (2013) Female sex hormones ameliorate arthritis in SKG mice. Biochem Biophys Res Commun 434 740-745.
149. Z Yan, NC Lambert, M Ostensen, et al. (2006) Prospective study of fetal DNA in serum and disease activity during pregnancy in women with inflammatory arthritis. Arthritis Rheum 54 2069.
150. JL Nelson, KA Hughes, AG Smith, et al. (1993) Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med 329 466.
151. P Brennan, J Barrett, M Fiddler, et al. (2000) Maternal-fetal HLA incompatibility and the course of inflammatory arthritis during pregnancy. J Rheumatol 27 2843.
152. E Karouzakis, Y Rengel, A Jüngel, et al. (2011) DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts. Genes Immun 12 643-652.
153. K Nakano, JW Whitaker, DL Boyle, et al. (2013) DNA methylome signature in rheumatoid arthritis. Ann Rheum Dis 72 110-117.
154. K Nakano, DL Boyle and GS Firestein (2013) Regulation of DNA methylation in rheumatoid arthritis synoviocytes. J Immunol 190 1297-1303.
155. LC Huber, M Brock, H Hemmatazad, et al. (2007) Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients. Arthritis Rheum 56 1087-1093.
156. M Horiuchi, A Morinobu, T Chin, et al. (2009) Expression and function of histone deacetylases in rheumatoid arthritis synovial fibroblasts. J Rheumatol 36 1580-1589.
157. LA Joosten, F Leoni, S Meghji, et al. (2011) Inhibition of HDAC activity by ITF2357 ameliorates joint inflammation and prevents cartilage and bone destruction in experimental arthritis. Mol Med 17 391-396.
158. Y Nakamachi, S Kawano, M Takenokuchi, et al. (2009) MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum 60 1294.
159. J Stanczyk, C Ospelt, E Karouzakis, et al. (2011) Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis Rheum 63 373-381.
160. M Kurowska-Stolarska, S Alivernini, LE Ballantine, et al. (2011) MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci U S A 108 11193-11198.
161. N Bottini and GS Firestein (2013) Epigenetics in rheumatoid arthritis: a primer for rheumatologists. Curr Rheumatol Rep 15 372.
162. MF Doran, GR Pond, CS Crowson, et al. (2002) Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum 46 625.
163. E Myasoedova, CS Crowson, HM Kremers, et al. (2010) Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum 62 1576-1582.
164. CS Crowson, EL Matteson, E Myasoedova, et al. (2011) The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum 63 633-639.
165. S Abdollahi-Roodsaz, LA Joosten, MI Koenders, et al. (2009) Local interleukin-1-driven joint pathology is dependent on toll-like receptor 4 activation. Am J Pathol 175 2004.
166. RJ Mathews, JI Robinson, M Battellino, et al. (2014) Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment. Ann Rheum Dis 73 1202-1210.
167. JY Choe, B Crain, SR Wu, et al. (2003) Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by toll-like receptor 4 signaling. J Exp Med 197 537.
168. M Brisslert, M Rehnberg and MI Bokarewa (2013) Epstein-Barr virus infection transforms CD25+ B cells into antibody-secreting cells in rheumatoid arthritis patients. Immunology 140 421-429.
169. A Kotlarz, S Tukaj, K Krzewski, et al. (2013) Human Hsp40 proteins, DNAJA1 and DNAJA2, as potential targets of the immune response triggered by bacterial DnaJ in rheumatoid arthritis. Cell Stress Chaperones 18 653-659.
170. NB Ray, DR Nieva, EA Seftor, et al. (2001) Induction of an invasive phenotype by human parvovirus B19 in normal human synovial fibroblasts. Arthritis Rheum 44 1582.
171. K Thammasri, S Rauhamäki, L Wang, et al. (2013) Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells. PLoS ONE 8 e67179.
172. L De Rycke, AP Nicholas, T Cantaert, et al. (2005) Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity. Arthritis Rheum 52 2323.
173. ER Vossenaar, TJ Smeets, MC Kraan, et al. (2004) The presence of citrullinated proteins is not specific for rheumatoid synovial tissue. Arthritis Rheum 50 3485.
174. C Anzilotti, G Merlini, F Pratesi, et al. (2006) Antibodies to viral citrullinated peptide in rheumatoid arthritis. J Rheumatol 33 647.
175. L Damjanovska, MM Thabet, EW Levarth, et al. (2010) Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis. Ann Rheum Dis 69 730.
176. GJ Pruijn, A Wiik and WJ van Venrooij (2010) The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis. Arthritis Res Ther 12 203.
177. CA Wagner, J Sokolove, LJ Lahey, et al. (2015) Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 “shared epitope” alleles. Ann Rheum Dis 74 579-586.
178. MM Nielen, D van Schaardenburg, HW Reesink, et al. (2004) Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 50 38.
179. LA van de Stadt, AR van der Horst, MH de Koning, et al. (2011) The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia. Ann Rheum Dis 70 128.
180. KD Deane, CI O'Donnell, W Hueber, et al. (2010) The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner. Arthritis Rheum 62 3161.
181. HS El-Gabalawy, DB Robinson, D Hart, et al. (2009) Immunogenetic risks of anti-cyclical citrullinated peptide antibodies in a North American Native population with rheumatoid arthritis and their first-degree relatives. J Rheumatol 6 1130.
182. FJ López-Longo, D Oliver-Miñarro, I de la Torre, et al. (2009) Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis. Arthritis Rheum 61 419.
183. EM Haisma, EW Levarht, D van der Woude, et al. (2009) Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. Arthritis Rheum 60 1923.
184. KA Kuhn, L Kulik, B Tomooka, et al. (2006) Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 116 961.
185. JA Hill, DA Bell, W Brintnell, et al. (2008) Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. J Exp Med 205 967.
186. H Burkhardt, B Sehnert, R Bockermann, et al. (2005) Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis. Eur J Immunol 35 1643.
187. R Kocijan, U Harre and G Schett (2013) ACPA and bone loss in rheumatoid arthritis. Curr Rheumatolog Rep 15 366.
188. J Shi, R Knevel, P Suwannalai, et al. (2011) Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc Natl Acad Sci U S A 108 17372-17377.
189. J Shi, LA van de Stadt, EW Levarht, et al. (2014) Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis. Ann Rheum Dis 73 780-783.
190. P Mydel, Z Wang, M Brisslert, et al. (2010) Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis. J Immunol 184 6882-6890.
191. KP Liang, H Maradit Kremers, CS Crowson, et al. (2009) Autoantibodies and the risk of cardiovascular events. J Rheumatol 36 2462-2468.
192. JP Bouvet, WJ Xin and J Pillot (1987) Restricted heterogeneity of polyclonal rheumatoid factor. Arthritis Rheum 30 998.
193. SK Lee, SL Bridges Jr, WJ Koopman, et al. (1992) The immunoglobulin kappa light chain repertoire expressed in the synovium of a patient with rheumatoid arthritis. Arthritis Rheum 35 905.
194. J Bäcklund, S Carlsen, T Höger, et al. (2002) Predominant selection of T cells specific for the glycosylated collagen type II epitope (263–270) in humanized transgenic mice and in rheumatoid arthritis. Proc Natl Acad Sci U S A 10 1073.
195. WC Watson, MA Cremer, PH Wooley, et al. (1986) Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis. Arthritis Rheum 29 1316.
196. T Sekine, K Masuko-Hongo, T Matsui, et al. (2001) Recognition of YKL-39, a human cartilage related protein, as a target antigen in patients with rheumatoid arthritis. Ann Rheum Dis 60 49.
197. W Hueber, BA Kidd, BH Tomooka, et al. (2005) Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum 52(9), 2645-2655.
198. G Steiner and J Smolen (2002) Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res 4 S1.
199. V Kouskoff, AS Korganow, V Duchatelle, et al. (1996) Organ-specific disease provoked by systemic autoimmunity. Cell 87 811.
200. L Mandik-Nayak and PM Allen (2005) Initiation of an autoimmune response: insights from a transgenic model of rheumatoid arthritis. Immunol Res 32 5.
201. S Hayer, M Tohidast-Akrad, S Haralambous, et al. (2005) Aberrant expression of the autoantigen heterogeneous nuclear ribonucleoprotein-A2 (RA33) and spontaneous formation of rheumatoid arthritis-associated anti-RA33 autoantibodies in TNF-alpha transgenic mice. J Immunol 175 8327.
202. V Nell-Duxneuner, K Machold, T Stamm, et al. (2010) Autoantibody profiling in patients with very early rheumatoid arthritis: a follow-up study. Ann Rheum Dis 69 169.
203. VP Nell, KP Machold, TA Stamm, et al. (2005) Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis 64 1731.
204. M Corr and NJ Zvaifler (2002) Mesenchymal precursor cells. Ann Rheum Dis 61 3.
205. HP Kiener, GF Watts, Y Cui, et al. (2010) Synovial fibroblasts self-direct multicellular lining architecture and synthetic function in three-dimensional organ culture. Arthritis Rheum 62 742.
206. PA Revell, PI Mapp, PA Lalor, et al. (1987) Proliferative activity of cells in the synovium as demonstrated by a monoclonal antibody, Ki67. Rheumatol Int 7 183.
207. X Valencia, JM Higgins, HP Kiener, et al. (2004) Cadherin-11 provides specific cellular adhesion between fibroblast-like synoviocytes. J Exp Med 200 1673.
208. TC van der Pouw Kraan, FA van Gaalen, PV Kasperkovitz, et al. (2003) Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum 48 2132.
209. S You, SA Yoo, S Choi, et al. (2014) Identification of key regulators for the migration and invasion of rheumatoid synoviocytes through a systems approach. Proc Natl Acad Sci U S A 111 550-555.
210. R Lafyatis, EF Remmers, AB Roberts, et al. (1989) Anchorage-independent growth of synoviocytes from arthritis and normal joints: stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. J Clin Invest 83 1267.
211. F Imamura, H Aono, T Hasunuma, et al. (1998) Monoclonal expansion of synoviocytes in rheumatoid arthritis. Arthritis Rheum 41 1979.
212. L Muller-Ladner, J Kriegsmann, BN Franklin, et al. (1996) Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 149 1607.
213. S Lefèvre, A Knedla, C Tennie, et al. (2009) Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med 15 1414.
214. A Lee, Y Qiao, G Grigoriev, et al. (2013) Tumor necrosis factor α induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 65 928-938.
215. B Bartok, D Hammaker and GS Firestein (2014) Phosphoinositide 3-kinase δ regulates migration and invasion of synoviocytes in rheumatoid arthritis. J Immunol 192 2063-2070.
216. JD Cañete, B Santiago, T Cantaert, et al. (2007) Ectopic lymphoid neogenesis in psoriatic arthritis. Ann Rheum Dis 66 720.
217. T Cantaert, J Kolln, T Timmer, et al. (2008) B lymphocyte autoimmunity in rheumatoid synovitis is independent of ectopic lymphoid neogenesis. J Immunol 181 785.
218. A Manzo, S Paoletti, M Carulli, et al. (2005) Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis. Eur J Immunol 35 1347.
219. T Tsubaki, S Takegawa, H Hanamoto, et al. (2005) Accumulation of plasma cells expressing CXCR3 in the synovial sublining regions of early rheumatoid arthritis in association with production of Mig/CXCL9 by synovial fibroblasts. Clin Exp Immunol 141 363.
220. YM Kang, X Zhang, UG Wagner, et al. (2002) CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis. J Exp Med 195 1325.
221. WJ Kim, YJ Kang, EM Koh, et al. (2005) LIGHT is involved in the pathogenesis of rheumatoid arthritis by inducing the expression of pro-inflammatory cytokines and MMP-9 in macrophages. Immunology 114 272.
222. RA Fava, E Notidis, J Hunt, et al. (2003) A role for the lymphotoxin/LIGHT axis in the pathogenesis of murine collagen-induced arthritis. J Immunol 171 115.
223. JS Park, MK Park, SY Lee, et al. (2012) TWEAK promotes the production of Interleukin-17 in rheumatoid arthritis. Cytokine 60 143-149.
224. K Hirota, H Yoshitomi, M Hashimoto, et al. (2007) Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med 204 2803.
225. Y Yamanishi, K Hiyama, S Ishioka, et al. (1999) Telomerase activity in the synovial tissues of chronic inflammatory and non-inflammatory rheumatic diseases. Int J Mol Med 4 513.
226. H Hata, N Sakaguchi, H Yoshitomi, et al. (2004) Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J Clin Invest 114 582.
227. GS Firestein (2014) The disease formerly known as rheumatoid arthritis. Arthritis Res Ther 16(3), 114.
228. D Burger, R Rezzonico, JM Li, et al. (1998) Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines. Arthritis Rheum 41 1748.
229. IB McInnes, BP Leung, RD Sturrock, et al. (1997) Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nat Med 3 189-195.
230. MA Quinn, PG Conaghan, PJ O'Connor, et al. (2005) Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial. Arthritis Rheum 52 27.
231. B Moradi, P Schnatzer, S Hagmann, et al. (2014) CD4+CD25+/highCD127low/- regulatory T cells are enriched in rheumatoid arthritis and osteoarthritis joints—analysis of frequency and phenotype in synovial membrane, synovial fluid and peripheral blood. Arthritis Res Ther 16 R97.
232. CR Ruprecht, M Gattorno, F Ferlito, et al. (2005) Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J Exp Med 201 1793.
233. XQ E, HX Meng, Y Cao, et al. (2012) Distribution of regulatory T cells and interaction with dendritic cells in the synovium of rheumatoid arthritis. Scand J Rheumatol 41 413-420.
234. JH Ju, YJ Heo, ML Cho, et al. (2012) Modulation of STAT-3 in rheumatoid synovial T cells suppresses Th17 differentiation and increases the proportion of Treg cells. Arthritis Rheum 64 3543-3552.
235. MN Svensson, SE Andersson, MC Erlandsson, et al. (2013) Fms-like tyrosine kinase 3 ligand controls formation of regulatory T cells in autoimmune arthritis. PLoS ONE 8 e54884.
236. MR Ehrenstein, JG Evans, A Singh, et al. (2004) Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 200 277.
237. S Xinqiang, L Fei, L Nan, et al. (2010) Therapeutic efficacy of experimental rheumatoid arthritis with low-dose methotrexate by increasing partially CD4(+)CD25(+)Treg cells and inducing Th1 to Th2 shift in both cells and cytokines. Biomed Pharmacother 64 463-471.
238. ME Morgan, R Flierman, LM van Duivenvoorde, et al. (2005) Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum 52 2212.
239. H Wang, SA Marsters, T Baker, et al. (2001) TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice. Nat Immunol 2 632.
240. TM Seyler, YW Park, S Takemura, et al. (2005) BLyS and APRIL in rheumatoid arthritis. J Clin Invest 115 3083.
241. PP Tak, RM Thurlings, C Rossier, et al. (2008) Atacicept in patients with rheumatoid arthritis: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose study. Arthritis Rheum 58 61.
242. BE Clausen, SL Bridges Jr, JC Lavelle, et al. (1998) Clonally-related immunoglobulin VH domains and nonrandom use of DH gene segments in rheumatoid arthritis synovium. Mol Med 4 240.
243. S Rosengren, N Wei, KC Kalunian, et al. (2011) CXCL13: a novel biomarker of B-cell return following rituximab treatment and synovitis in patients with rheumatoid arthritis. Rheumatology (Oxford) 50 603-610.
244. K Owczarczyk, P Lal, AR Abbas, et al. (2011) A plasmablast biomarker for nonresponse to antibody therapy to CD20 in rheumatoid arthritis. Sci Transl Med 3 101ra92.
245. A Kavanaugh, S Rosengren, SJ Lee, et al. (2008) Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results. Ann Rheum Dis 67 402.
246. S Takemura, PA Klimiuk, A Braun, et al. (2001) T cell activation in rheumatoid synovium is B cell dependent. J Immunol 167 4710.
247. L Yeo, H Lom, M Juarez, et al. (2015) Expression of FcRL4 defines a pro-inflammatory, RANKL-producing B cell subset in rheumatoid arthritis. Ann Rheum Dis 74 928-935.
248. F Humby, M Bombardieri, A Manzo, et al. (2009) Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med 6 e1.
249. KP MacDonald, AR Pettit, C Quinn, et al. (1999) Resistance of rheumatoid synovial dendritic cells to the immunosuppressive effects of IL-10. J Immunol 163 5599.
250. ML Toh, JY Bonnefoy, N Accart, et al. (2014) A CSF-1 receptor monoclonal antibody has potent bone and cartilage protective effects in experimental arthritis. Arthritis Rheumatol 66 2989-3000.
251. DG Malone, RL Wilder, AM Saavedra-Delgado, et al. (1987) Mast cell numbers in rheumatoid synovial tissues. Arthritis Rheum 30 130.
252. H Lee, J Kashiwakura, A Matsuda, et al. (2013) Activation of human synovial mast cells from rheumatoid arthritis or osteoarthritis patients in response to aggregated IgG through Fcγ receptor I and Fcγ receptor II. Arthritis Rheum 65 109-119.
253. DM Lee, DS Friend, MF Gurish, et al. (2002) Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297 1689.
254. N Schubert, J Dudeck, P Liu, et al. (2015) Mast cell promotion of T cell-driven antigen-induced arthritis despite being dispensable for antibody-inducedarthritis in which T cells are bypassed. Arthritis Rheumatol 67(4), 903-913. 10.1002/art.38996
255. A Juurikivi, C Sandler, KA Lindstedt, et al. (2005) Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis. Ann Rheum Dis 64 1126.
256. AJ Hueber, DL Asquith, AM Miller, et al. (2010) Mast cells express IL-17A in rheumatoid arthritis synovium. J Immunol 184 3336.
257. R Khandpur, C Carmona-Rivera, A Vivekanandan-Giri, et al. (2013) NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med 5 178ra40.
258. N Dwivedi and M Radic (2014) Citrullination of autoantigens implicates NETosis in the induction of autoimmunity. Ann Rheum Dis 73 483-491.
259. PP Tak, JA Kummer, CE Hack, et al. (1994) Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue. Arthritis Rheum 37 1735.
260. N Dalbeth, R Gundle, RJ Davies, et al. (2004) CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J Immunol 173 6418.
261. YE Park, GT Kim, SG Lee, et al. (2013) IL-32 aggravates synovial inflammation and bone destruction and increases synovial natural killer cells in experimental arthritis models. Rheumatol Int 33 671-679.
262. L Marinova-Mutafchieva, RO Williams, K Funa, et al. (2002) Inflammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis. Arthritis Rheum 46 507.
263. G Schett and GS Firestein (2010) Mr Outside and Mr Inside: classic and alternative views on the pathogenesis of rheumatoid arthritis. Ann Rheum Dis 69 787.
264. JM Hughes-Austin, KD Deane, LA Derber, et al. (2013) Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA). Ann Rheum Dis 72 901-907.
265. Z Han, DL Boyle, AM Manning, et al. (1998) AP-1 and NF-κB regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity 28 197.
266. MJ de Hair, MG van de Sande, TH Ramwadhdoebe, et al. (2014) Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis. Arthritis Rheumatol 66 513-522.
267. H Liao, J Wu, E Kuhn, et al. (2004) Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum 50 3792.
268. AE Tutturen, B Fleckenstein and GA de Souza (2014) Assessing the citrullinome in rheumatoid arthritis synovial fluid with and without enrichment of citrullinated peptides. J Proteome Res 13 2867-2873.
269. V Romero, J Fert-Bober, PA Nigrovic, et al. (2013) Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis. Sci Transl 5 209ra150.
270. H Jonsson, P Allen and SL Peng (2005) Inflammatory arthritis requires Foxo3a to prevent Fas ligand-induced neutrophil apoptosis. Nat Med 11 666.
271. GS Firestein, AE Berger, DE Tracey, et al. (1992) IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium. J Immunol 149 1054.
272. GS Firestein, AE Berger, DE Tracey, et al. (1992) IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium. J Immunol 149 1054.
273. N Cloutier, S Tan, LH Boudreau, et al. (2013) The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle-associated immune complexes. EMBO Mol Med 5 235-249.
274. CE Vergunst, DM Gerlag, H Dinant, et al. (2007) Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation. Rheumatology (Oxford) 46 1773.
275. I Siegle, T Klein, JT Backman, et al. (1998) Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases. Arthritis Rheum 41 122.
276. C Yao, D Sakata, Y Esaki, et al. (2009) Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat Med 15 633.
277. J Elmgreen, N Haagen and I Ahnfelt-Ronne (1987) Enhanced capacity for release ofleukotriene B4 by neutrophils in rheumatoid arthritis. Ann Rheum Dis 46 501.
278. JSH Gaston, AB Rickinson, QY Yao, et al. (1986) The abnormal cytotoxic T cell response to Epstein-Barr virus in rheumatoid arthritis is correlated with disease activity and occurs in other arthropathies. Ann Rheum Dis 45 932.
279. JJ Goronzy and CM Weyand (2001) Thymic function and peripheral T-cell homeostasis in rheumatoid arthritis. Trends Immunol 22 251.
280. V Goëb, P Aegerter, R Parmar, et al. (2013) Progression to rheumatoid arthritis in early inflammatory arthritis is associated with low IL-7 serum levels. Ann Rheum Dis 72 1032-1036.
281. EN Unemori, MJ Bair, EA Bauer, et al. (1991) Stromelysin expression regulates collagenase activation in human fibroblasts. Dissociable control of two metalloproteinases by interferon-gamma. J Biol Chem 266 23477.
282. GS Firestein, WD Xu, K Townsend, et al. (1988) Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis. J Exp Med 168 1573.
283. K Raza, F Falciani, SJ Curnow, et al. (2005) Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther 7 R784.
284. M Chabaud, JM Durand, N Buchs, et al. (1999) Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 43 963.
285. MI Koenders, E Lubberts, FA van de Loo, et al. (2006) Interleukin-17 acts independently of TNF-alpha under arthritic conditions. J Immunol 176 6262.
286. MC Genovese, F Van den Bosch, SA Roberson, et al. (2010) LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis Rheum 62 929.
287. P Chomarat, J Banchereau and P Miossec (1995) Differential effects of interleukins 10 and 4 on the production of interleukin-6 by blood and synovium monocytes in rheumatoid arthritis. Arthritis Rheum 38 1046.
288. KD Katsikis, CQ Chu, FM Brennan, et al. (1994) Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 179 1517.
289. LA Joosten, E Lubberts, P Durez, et al. (1997) Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis: protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum 40 249.
290. LAB Joosten, E Lubberts, MMA Helsen, et al. (1997) Dual role of IL-12 in early and late stages of murine collagen type II arthritis. J Immunol 159 4094.
291. W Hueber, DD Patel, T Dryja, et al. (2010) Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med 2 52ra72.
292. TJ Smeets, MC Kraan, J Versendaal, et al. (1999) Analysis of serial synovial biopsies in patients with rheumatoid arthritis: description of a control group without clinical improvement after treatment with interleukin 10 or placebo. J Rheumatol 26 2089.
293. JM Hughes-Austin, KD Deane, LA Derber, et al. (2013) Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA). Ann Rheum Dis 72 901-907.
294. GS Firestein, JM Alvaro-Gracia and R Maki (1990) Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 144 3347.
295. MC Genovese, S Cohen, L Moreland, et al. (2004) Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate. Arthritis Rheum 50 1412.
296. LA Joosten, FA van De Loo, E Lubberts, et al. (2000) An IFN-gamma-independent proinflammatory role of IL-18 in murine streptococcal cell wall arthritis. J Immunol 165 6553.
297. D Xu, HR Jiang, P Kewin, et al. (2008) IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci U S A 105 10913.
298. Y Qin, Y Chen, W Wang, et al. (2014) HMGB1-LPS complex promotes transformation of osteoarthritis synovial fibroblasts to a rheumatoid arthritis synovial fibroblast-like phenotype. Cell Death Dis 5 e1077.
299. S Georgopoulos, D Plows and G Kollias (1996) Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice. J Inflamm 46 86.
300. RO Williams, LJ Mason, M Feldmann, et al. (1994) Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis. Proc Natl Acad Sci U S A 91 2762.
301. PE Lipsky, DM van der Heijde, EW St Clair, et al. (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. N Engl J Med 343 1594.
302. J Lindberg, CA Wijbrandts, LG van Baarsen, et al. (2010) The gene expression profile in the synovium as a predictor of the clinical response to infliximab treatment in rheumatoid arthritis. PLoS ONE 5 e11310.
303. N Nishimoto, K Yoshizaki, N Miyasaka, et al. (2004) Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 50 1761.
304. A Kavanaugh, C Ritchlin, P Rahman, et al. (2014) Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials. PSUMMIT-1 and 2 Study Groups. Ann Rheum Dis 73(6), 1000-1006.
305. B Baslund, N Tvede, B Danneskiold-Samsoe, et al. (2005) Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study. Arthritis Rheum 52 2686.
306. LA Joosten, MG Netea, SH Kim, et al. (2006) IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci U S A 103 3298.
307. WD Xu, GS Firestein, R Taetle, et al. (1989) Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions. J Clin Invest 83 876.
308. F Behrens, PP Tak, M Ostergaard, et al. (2015) MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial. Ann Rheum Dis 74 1058-1064.
309. SJ Moon, YS Hong, JH Ju, et al. (2013) Increased levels of interleukin 34 in serum and synovial fluid are associated with rheumatoid factor and anticyclic citrullinated peptide antibody titers in patients with rheumatoid arthritis. J Rheumatol 40 1842-1849.
310. M Corr, DL Boyle, LM Ronacher, et al. (2011) Interleukin 1 receptor antagonist mediates the beneficial effects of systemic interferon beta in mice: implications for rheumatoid arthritis. Ann Rheum Dis 70 858-863.
311. F Wang, L Xu, X Feng, et al. (2012) Interleukin-29 modulates proinflammatory cytokine production in synovial inflammation of rheumatoid arthritis. Arthritis Res Ther 14 R228.
312. AE Koch, SL Kunkel, JC Burrows, et al. (1991) Synovial tissue macrophage as a source of the chemotactic cytokine IL-8. J Immunol 147 2187.
313. AE Koch, SL Kunkel, LA Harlow, et al. (1994) Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis. J Clin Invest 94 1012.
314. C Schmutz, A Hulme, A Burman, et al. (2005) Chemokine receptors in the rheumatoid synovium: upregulation of CXCR5. Arthritis Res Ther 7 R217.
315. T Nanki, Y Urasaki, T Imai, et al. (2004) Inhibition of fractalkine ameliorates murine collagen-induced arthritis. J Immunol 173 7010.
316. M Yellin, I Paliienko, A Balanescu, et al. (2012) A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 64 1730-1739.
317. JJ Haringman, TJ Smeets, P Reinders-Blankert, et al. (2006) Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis. Ann Rheum Dis 65 294.
318. M Camps, T Ruckle, H Ji, et al. (2005) Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 11 936.
319. M Malyak, RE Swaney and WP Arend (1993) Levels of synovial fluid interleukin-1 receptor antagonist in rheumatoid arthritis and other arthropathies: potential contribution from synovial fluid neutrophils. Arthritis Rheum 36 781.
320. RA Fava, NJ Olsen, G Spencer-Green, et al. (1994) Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 180 34.
321. M Sioud, O Mellbye and O Forre (1998) Analysis of the NF-kappa B p65 subunit, Fas antigen, Fas ligand and Bcl-2–related proteins in the synovium of RA and polyarticular JRA. Clin Exp Rheumatol 16 125.
322. C Zaph, AE Troy, BC Taylor, et al. (2007) Epithelial-cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis. Nature 446(7135), 552-556.
323. PP Tak, DM Gerlag, KB Aupperle, et al. (2001) Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation. Arthritis Rheum 44 1897.
324. Z Han, DL Boyle, AM Manning, et al. (1998) AP-1 and NF-κB regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity 28 197.
325. S Wakisaka, N Suzuki, N Saito, et al. (1998) Possible correction of abnormal rheumatoid arthritis synovial cell function by jun D transfection in vitro. Arthritis Rheum 41 470.
326. DL Boyle, TL Jones, D Hammaker, et al. (2006) Regulation of peripheral inflammation by spinal p38 MAP kinase in rats. PLoS Med 3(9), e338.
327. D Hammaker and GS Firestein (2010) “Go upstream, young man”: lessons learned from the p38 saga. Ann Rheum Dis 69(Suppl 1), i77.
328. M Guma, D Hammaker, K Topolewski, et al. (2012) Antiinflammatory functions of p38 in mouse models of rheumatoid arthritis: advantages of targeting upstream kinases MKK-3 or MKK-6. Arthritis Rheum 64 2887-2895.
329. T Inoue, DL Boyle, M Corr, et al. (2006) Mitogen-activated protein kinase kinase 3 is a pivotal pathway regulating p38 activation in inflammatory arthritis. Proc Natl Acad Sci U S A 103 5484.
330. Z Han, DL Boyle, L Chang, et al. (2001) c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest 108 73.
331. T Inoue, D Hammaker, DL Boyle, et al. (2006) Regulation of JNK by MKK-7 in fibroblast-like synoviocytes. Arthritis Rheum 54 2127.
332. SI Lee, DL Boyle, A Berdeja, et al. (2012) Regulation of inflammatory arthritis by the upstream kinase mitogen activated protein kinase kinase 7 in the c-Jun N-terminal kinase pathway. Arthritis Res Ther 14 R38.
333. JG Walker, MJ Ahern, M Coleman, et al. (2007) Characterisation of a dendritic cell subset in synovial tissue which strongly expresses Jak/STAT transcription factors from patients with rheumatoid arthritis. Ann Rheum Dis 66 992.
334. R Stillie, SM Farooq, JR Gordon, et al. (2009) The functional significance behind expressing two IL-8 receptor types on PMN. J Leukoc Biol 86 529.
335. M Huckel, U Schurigt, AH Wagner, et al. (2005) Attenuation of murine antigen-induced arthritis by treatment with a decoy oligodeoxynucleotide inhibiting signal transducer and activator of transcription-1 (STAT-1). Arthritis Res Ther 8 R17.
336. TC van der Pouw Kraan, FA van Gaalen, PV Kasperkovitz, et al. (2003) Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum 48 2132.
337. DL Boyle, K Soma, J Hodge, et al. (2015) The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis. Ann Rheum Dis 74(6), 1311-1316.
338. SE Sweeney, D Hammaker, DL Boyle, et al. (2005) Regulation of c-Jun phosphorylation by the I kappa B kinase-epsilon complex in fibroblast-like synoviocytes. J Immunol 174 6424.
339. SE Sweeney, TB Kimbler and GS Firestein (2010) Synoviocyte innate immune responses: II. Pivotal role of IFN regulatory factor 3. J Immunol 184 7162-7168.
340. M Corr, DL Boyle, L Ronacher, et al. (2009) Synergistic benefit in inflammatory arthritis by targeting I kappaB kinase epsilon and interferon beta. Ann Rheum Dis 68 257.
341. ME Weinblatt, A Kavanaugh, R Burgos-Vargas, et al. (2008) Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial. Arthritis Rheum 58 3309.
342. CT Chou, JS Yang and MR Lee (2001) Apoptosis in rheumatoid arthritis: expression of Fas, Fas-L, p53, and Bcl-2 in rheumatoid synovial tissues. J Pathol 193 110.
343. J Morel, R Audo, M Hahne, et al. (2005) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt. J Biol Chem 280 15709.
344. AI Catrina, AK Ulfgren, S Lindblad, et al. (2002) Low levels of apoptosis and high FLIP expression in early rheumatoid arthritis synovium. Ann Rheum Dis 61 934.
345. HS Cha, S Rosengren, DL Boyle, et al. (2006) PUMA regulation and proapoptotic effects in fibroblast-like synoviocytes. Arthritis Rheum 254 587.
346. BB Böhm, I Freund, K Krause, et al. (2013) ADAM15 adds to apoptosis resistance of synovial fibroblasts by modulating focal adhesion kinase signaling. Arthritis Rheum 65 2826-2834.
347. JW Whitaker, R Shoemaker, DL Boyle, et al. (2013) An imprinted rheumatoid arthritis methylome signature reflects pathogenic phenotype. Genome Med 5 40.
348. T Pap, JK Franz, KM Hummel, et al. (2000) Activation of synovial fibroblasts in rheumatoid arthritis: lack of expression of the tumour suppressor PTEN at sites of invasive growth and destruction. Arthritis Res 2 59.
349. M Kato, C Ospelt, RE Gay, et al. (2014) Dual role of autophagy in stress-induced cell death in rheumatoid arthritis synovial fibroblasts. Arthritis Rheumatol 66 40-48.
350. Q Yao, DW Seol, Z Mi, et al. (2005) Intra-articular injection of recombinant TRAIL induces synovial apoptosis and reduces inflammation in a rabbit knee model of arthritis. Arthritis Res Ther 8 R16.
351. JC Scatizzi, J Hutcheson, RM Pope, et al. (2010) Bim-Bcl-2 homology 3 mimetic therapy is effective at suppressing inflammatory arthritis through the activation of myeloid cell apoptosis. Arthritis Rheum 62 441.
352. Q Yao, S Wang, JC Glorioso, et al. (2001) Gene transfer of p53 to arthritic joints stimulates synovial apoptosis and inhibits inflammation. Mol Ther 3 901.
353. Y Yamanishi, DL Boyle, MJ Pinkoski, et al. (2002) Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis. Am J Pathol 160 123.
354. GS Firestein, K Nguyen, K Aupperle, et al. (1996) Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am J Pathol 149 2143.
355. GS Firestein, F Echeverri, M Yeo, et al. (1997) Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci U S A 94 10895.
356. JS Park, MA Lim, ML Cho, et al. (2013) p53 controls autoimmune arthritis via STAT-mediated regulation of the Th17 cell/Treg cell balance in mice. Arthritis Rheum 65 949-959.
357. E Izquierdo, JD Cañete, R Celis, et al. (2009) Immature blood vessels in rheumatoid synovium are selectively depleted in response to anti-TNF therapy. PLoS ONE 4 e8131.
358. CR Stevens, DR Blake, P Merry, et al. (1991) A comparative study by morphometry of the microvasculature in normal and rheumatoid synovium. Arthritis Rheum 34 1508.
359. T Cramer, Y Yamanishi, BE Clausen, et al. (2003) HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112 645.
360. F Hu, L Shi, R Mu, et al. (2013) Hypoxia-inducible factor-1α and interleukin 33 form a regulatory circuit to perpetuate the inflammation in rheumatoid arthritis. PLoS ONE 8 e72650.
361. W Gao, J McCormick, M Connolly, et al. (2014) Hypoxia and STAT3 signalling interactions regulate pro-inflammatory pathways in rheumatoid arthritis. Ann Rheum Dis
362. MG van de Sande, D de Launay, MJ de Hair, et al. (2013) Local synovial engagement of angiogenic TIE-2 is associated with the development of persistent erosive rheumatoid arthritis in patients with early arthritis. Arthritis Rheum 65 3073-3083.
363. AE Koch, MM Halloran, CJ Haskell, et al. (1995) Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376 517.
364. MA Amin, PL Campbell, JH Ruth, et al. (2015) A key role for Fut1-regulated angiogenesis and ICAM-1 expression in K/BxN arthritis. Ann Rheum Dis 74 1459-1466.
365. DJ Peacock, ML Banquerigo and E Brahn (1992) Angiogenesis inhibition suppresses collagen arthritis. J Exp Med 175 1135.
366. J Shankar, PB Thippegowda and SA Kanum (2009) Inhibition of HIF-1alpha activity by BP-1 ameliorates adjuvant induced arthritis in rats. Biochem Biophys Res Commun 387 223.
367. BJ Rabquer and AE Koch (2013) NK4 therapy: a new approach to target angiogenesis and inflammation in rheumatoid arthritis. Arthritis Res Ther 15 119.
368. CM Storgard, DG Stupack, A Jonczyk, et al. (1998) Decreased angiogenesis and arthritis in rabbits treated with an αvβ3 antagonist. J Clin Invest 103 47.
369. DM Gerlag, E Borges, PP Tak, et al. (2001) Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature. Arthritis Res 3 357.
370. LP Hale, ME Martin, DE McCollum, et al. (1989) Immunohistologic analysis of the distribution of cell adhesion molecules within the inflammatory synovial microenvironment. Arthritis Rheum 32 22.
371. TB Issekutz and AC Issekutz (1991) T lymphocyte migration to arthritic joints and dermal inflammation in the rat: differing migration patterns and the involvement of VLA-4. Clin Immunol Immunopathol 61 436.
372. MJ Elices, V Tsai, D Strahl, et al. (1994) Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature. J Clin Invest 93 405-416.
373. C Jorgensen, A Travaglio-Encinoza and C Bologna (1994) Human mucosal lymphocyte marker expression in synovial fluid lymphocytes of patients with rheumatoid arthritis. J Rheumatol 21 1602.
374. MA El Azreq, M Boisvert, A Cesaro, et al. (2013) α2β1 integrin regulates Th17 cell activity and its neutralization decreases the severity of collagen-induced arthritis. J Immunol 191 5941-5950.
375. C Jorgensen, I Couret, F Canovas, et al. (1996) Mononuclear cell retention in rheumatoid synovial tissue engrafted in severe combined immunodeficient (SCID) mice is up-regulated by tumour necrosis factor-alpha (TNF-alpha) and mediated through intercellular adhesion molecule-1 (ICAM-1). Clin Exp Immunol 106 20.
376. JH Ruth, MA Amin, JM Woods, et al. (2005) Accelerated development of arthritis in mice lacking endothelial selectins. Arthritis Res Ther 7 R959.
377. DM Lee, HP Kiener, SK Agarwal, et al. (2007) Cadherin-11 in synovial lining formation and pathology in arthritis. Science 315 1006.
378. GC Wolfe, KL MacNaul, FF Buechel, et al. (1993) Differential in vivo expression of collagenase messenger RNA in synovium and cartilage: quantitative comparison with stromelysin messenger RNA levels in human rheumatoid arthritis and osteoarthritis patients and in two animal models of acute inflammatory arthritis. Arthritis Rheum 36 1540.
379. EH Noss, SK Chang, GF Watts, et al. (2011) Modulation of matrix metalloproteinase production by rheumatoid arthritis synovial fibroblasts after cadherin 11 engagement. Arthritis Rheum 63 3768-3778.
380. GS Firestein, MM Paine and BH Littman (1991) Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium: quantitative analysis and effect of intraarticular corticosteroids. Arthritis Rheum 34 1094.
381. JS Mudgett, NI Hutchinson, NA Chartrain, et al. (1998) Susceptibility of stromelysin 1–deficient mice to collagen-induced arthritis and cartilage destruction. Arthritis Rheum 41 110.
382. R Lemaire, G Huet, F Zerimech, et al. (1997) Selective induction of the secretion of cathepsins B and L by cytokines in synovial fibroblast-like cells. Br J Rheumatol 36 735.
383. WS Hou, W Li, G Keyszer, et al. (2002) Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium. Arthritis Rheum 46 663.
384. L Svelander, H Erlandsson-Harris, L Astner, et al. (2009) Inhibition of cathepsin K reduces bone erosion, cartilage degradation and inflammation evoked by collagen-induced arthritis in mice. Eur J Pharmacol 613 155.
385. MW Lark, EK Bayne, J Flanagan, et al. (1997) Aggrecan degradation in human cartilage: evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. J Clin Invest 100 93.
386. Y Yamanishi, DL Boyle, M Clark, et al. (2002) Expression and regulation of aggrecanase in arthritis: the role of TGF-beta. J Immunol 168 1405.
387. H Stanton, FM Rogerson, CJ East, et al. (2005) ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434 648.
388. X Yan, L Yin, Y Wang, et al. (2013) The low binding affinity of ADAMTS4 for citrullinated fibronectin may contribute to the destruction of joint cartilage in rheumatoid arthritis. Clin Exp Rheumatol 31 201-206.
389. GS Firestein, MM Paine and DL Boyle (1994) Mechanisms of methotrexate action in rheumatoid arthritis: selective decrease in synovial collagenase gene expression. Arthritis Rheum 37 193.
390. D McGonagle, AL Tan, U Møller Døhn, et al. (2009) Microanatomic studies to define predictive factors for the topography of periarticular erosion formation in inflammatory arthritis. Arthritis Rheum 60 1042-1051.
391. D McGonagle, AL Tan, U Møller Døhn, et al. (2009) Microanatomic studies to define predictive factors for the topography of periarticular erosion formation in inflammatory arthritis. Arthritis Rheum 60(4), 1042-1051. 10.1002/art.24417
392. YY Kong, U Feige, I Sarosi, et al. (1999) Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402 304-309.
393. S Kotake, N Udagawa, M Hakoda, et al. (2001) Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum 44 1003.
394. A Deodhar, RK Dore, D Mandel, et al. (2010) Denosumab-mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients. Arthritis Care Res 62 569.
395. D Diarra, M Stolina, K Polzer, et al. (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13 156.
396. SK Kwok, ML Cho, MK Park, et al. (2012) Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis. Arthritis Rheum 64 740-751.
397. M Sen, M Chamorro, J Reifert, et al. (2001) Blockade of Wnt-5A/frizzled 5 signaling inhibits rheumatoid synoviocyte activation. Arthritis Rheum 44 772.
398. RJ Lories and FP Luyten (2005) Bone morphogenetic protein signaling in joint homeostasis and disease. Cytokine Growth Factor Rev 16 287.